As part of Seqirus’ commitment to providing education to our community about the unique venomous creatures that may cross the paths of Australians, we have introduced a free smartphone app – Australian Bites & Stings: First Aid Guide to Australian Venomous Creatures – which hosts up-to-date first aid information.
)
PRODUCTS
OUR PRODUCTS
Seqirus manufactures and in-licenses a wide range of vaccines, antivenoms and pharmaceutical products from our partner licensors to ensure these products are available to meet the needs of Australia's community at home and abroad.
The information provided below about our products is intended for use by :
- people in Australia who have been prescribed a Seqirus product, and
- healthcare professionals practicing in Australia.
Influenza
| Afluria® Quad | Inactivated Quadrivalent Influenza Vaccine (split viron) |
|
For the prevention of influenza in persons aged 5 years and over. MORE INFORMATION |
| Fluad® Quad | Inactivated Quadrivalent Influenza Vaccine (surface antigen), Adjuvanted |
|
For the prevention of influenza in persons aged 65 years and over MORE INFORMATION |
| Flucelvax® Quad | Quadrivalent Influenza Vaccine (surface antigen, inactivated, prepared in cell cultures) |
| Rapivab® | Peramivir Injection |
|
For the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days. MORE INFORMATION |
In-Licensed Vaccines
| ADT™ Booster | Diphtheria and Tetanus Vaccine (adsorbed) for revaccination |
|
For the prevention of diphtheria and tetanus in individuals who have previously received at least 3 doses of a vaccine for primary immunisation against diphtheria and tetanus. MORE INFORMATION |
| DUKORAL® | Oral inactivated cholera vaccine. |
|
For the prevention of Cholera caused by serogroup O1 Vibrio cholera in adults and children ≥ 2 years. MORE INFORMATION |
| GARDASIL® 9 | Human Papillomavirus 9-valent vaccine, Recombinant |
|
For the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts, external genital lesions, and infection caused by Human Papillomavirus (HPV) Types 6, 11, 16, 18, 31, 33, 45, 52 and 58. MORE INFORMATION |
| H-B-VAX® II | Hepatitis B vaccine (recombinant) |
|
For the prevention of hepatitis B infection. MORE INFORMATION |
| JESPECT® | Inactivated Japanese Encephalitis Vaccine (adsorbed) |
|
For the immunisation against Japanese Encephalitis infection for persons 18 years of age and older. MORE INFORMATION |
| M-M-R® II | Measles, Mumps and Rubella Virus Vaccine Live |
|
For the prevention of measles, mumps and rubella. MORE INFORMATION |
| PROQUAD® | Measles, Mumps, Rubella and Varicella Virus Vaccine Live |
|
For the prevention of measles, mumps, rubella and chickenpox in individuals 12 months through 12 years of age. MORE INFORMATION |
| PNEUMOVAX®23 | Pneumococcal vaccine, Polyvalent |
|
For the prevention of pneumococcal disease caused by infection with pneumococcal types included in the vaccine. MORE INFORMATION |
| RABIPUR® | Rabies virus vaccine (inactivated) |
|
Active immunisation against rabies virus, including a) Pre-exposure immunisation b) Post-exposure treatment following exposure to rabies virus. MORE INFORMATION |
| ROTATEQ® | Rotavirus Vaccine, Live, Oral, Pentavalent |
|
For the prevention of rotavirus gastroenteritis. MORE INFORMATION |
| VAQTA® | Hepatitis A vaccine, inactivated |
|
For the prevention of hepatitis A infection. MORE INFORMATION |
| VARIVAX® Refrigerated | Varicella Virus Vaccine Live |
|
For prevention of varicella infection in healthy individuals 12 months of age and older. MORE INFORMATION |
| ZOSTAVAX® | Zoster Virus Vaccine Live |
|
For the prevention of shingles in individuals 50 years of age and older. MORE INFORMATION |
In-Licensed Pharmaceuticals
| ACARIZAX® | Sublingual tablet of standardised allergen extract from the house dust mite species Dermaophagoides pteronyssinus and Dermatophagoides farinae. |
|
Allergy immunotherapy for the treatment of house dust mite allergic rhinitis and allergic asthma. MORE INFORMATION |
| BENPEN® | Benzylpenicillin (as benzylpenicillin sodium) Powder for Injection |
|
Used to treat infections caused by susceptible bacteria. MORE INFORMATION |
| CALDOLOR® | Ibuprofen IV concentrated injection |
|
For management of post-operative pain and fever MORE INFORMATION |
| CATIONORM® | Eye drop emulsion |
|
For the treatment of dry eye. |
| GRAZAX® | Sublingual tablet of standardised allergen extract of Timothy grass pollen (Phleum pratense). |
|
Allergy immunotherapy for the disease modifying treatment of grass pollen (Phleum pratense or allergens cross reacting with P. pratense) allergy. MORE INFORMATION |
| NERVODERM® | Lignocaine 5% w/w, Dermal Patch |
|
For the symptomatic relief of medically diagnosed neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) MORE INFORMATION |
| PALEXIA® SR | Tapentadol (as hydrochloride) sustained release |
|
Used in the management of severe pain in restricted circumstances [please refer to full PI]. MORE INFORMATION |
| PALEXIA® IR | Tapentadol (as hydrochloride) immediate release |
|
Used for the short-term management of severe pain in restricted circumstances [please refer to full PI]. MORE INFORMATION |
| RYALTRIS® | Nasal Spray │ Fixed dose combination of mometasone furoate monohydrate and olopatadine hydrochloride |
|
Indicated for the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 12 years of age and older. MORE INFORMATION |
| TEGLUTIK® | Riluzole 5mg/mL Oral Suspension |
|
For the treatment of patients with amyotrophic lateral sclerosis (ALS) MORE INFORMATION |
| TRAMAL® | Capsules and injections | Tramadol Hydrochloride |
|
Used in the management of severe pain in restricted circumstances [please refer to full PI]. MORE INFORMATION |
| TRAMAL® | Oral drops | Tramadol Hydrochloride |
|
Used for the short-term management of severe pain in restricted circumstances [please refer to full PI]. MORE INFORMATION |
| TRAMAL® | 50mg, 100mg, 150mg & 200mg Sustained Release Tablets | Tramadol Hydrochloride |
|
Used for the short-term management of severe pain in restricted circumstances [please refer to full PI]. MORE INFORMATION |
| VERSATIS® | Lignocaine 5% w/w, Dermal Patch |
|
For the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (postherpetic neuralgia). MORE INFORMATION |
| XADAGO® | Safinamide (as mesilate) tablet |
|
For the treatment of adults with fluctuating idiopathic Parkinson’s disease (PD) as add-on therapy to a regimen that includes levodopa (L-dopa) MORE INFORMATION |
| Q-VAX® | Q fever vaccine and skin test |
|
For the prevention of Q fever. MORE INFORMATION |
| Black Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Box Jellyfish Antivenom |
|
For the treatment of symptoms of a venomous sting. MORE INFORMATION |
| Brown Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Death Adder Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Funnel Web Spider Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Polyvalent Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Red Back Spider Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Sea Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Stonefish Antivenom |
|
For the treatment of symptoms of a venomous sting. MORE INFORMATION |
| Taipan Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Tiger Snake Antivenom |
|
For the treatment of symptoms of a venomous bite. MORE INFORMATION |
| Snake Venom Detection Kit | Snake Venom Detection |
|
For the in vitro detection and identification of land snake venom MORE INFORMATION |
Pandemic Response Solutions
As a global leader in influenza vaccine manufacturing, Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more
SEQ/CORP/1019/0027 October 2019